| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |